Our experts
We use a rigorous, independent funding review process shaped by a mix of leading global scientific experts and people living with MND.
Funding Application Review Process
All funding applications are assessed by our Translational Research Review Committee or our Discovery Network Advisory Board, who provide independent recommendations to our Board of Trustees. As a member of the Association of Medical Research Charities (AMRC), we follow their principles and standards for peer review.
Funding Application Review Process
All funding applications are assessed by our Translational Research Review Committee or our Discovery Network Advisory Board, who provide independent recommendations to our Board of Trustees. As a member of the Association of Medical Research Charities (AMRC), we follow their principles and standards for peer review.
Our Translational Research Review Committee
Our Translational Research Review Committee oversees the due diligence of our Advancing Treatments and Catalyst awards. As a collective of academics, clinicians, industry representatives, and people affected by MND, they are the specialists who ensure that we fund the most promising projects.
Prof Paul Matthews (Chair)
The Rosalind Franklin Institute
Prof Paul Matthews (Chair)
The Rosalind Franklin Institute
Dr Jill Richardson (Vice-Chair)
Pontaris Consulting Ltd
Dr Jill Richardson (Vice-Chair)
Pontaris Consulting Ltd
Nick Apperley
Affected by MND
Nick Apperley
Affected by MND
Ang Armstrong
Affected by MND
Ang Armstrong
Affected by MND
Dr Ruxandra Dafinca
University of Oxford
Dr Ruxandra Dafinca
University of Oxford
Dr Luc Dupuis
University of Strasbourg
Dr Luc Dupuis
University of Strasbourg
Dr Emily Feneberg
Technical University Munich
Dr Emily Feneberg
Technical University Munich
Prof Pietro Fratta
University College London
Prof Pietro Fratta
University College London
Dr Oliver Freeman
Astex Pharmaceuticals
Dr Oliver Freeman
Astex Pharmaceuticals
Anita Gajdecki
Affected by MND
Anita Gajdecki
Affected by MND
Prof Tom Gillingwater
University of Edinburgh
Prof Tom Gillingwater
University of Edinburgh
Dr John Hamlin
Affected by MND
Dr John Hamlin
Affected by MND
Sandra Harvey
Affected by MND
Sandra Harvey
Affected by MND
Prof Guillaume Hautbergue
University of Sheffield
Prof Guillaume Hautbergue
University of Sheffield
Dr Emma Jones
Medicines Discovery Catapult
Dr Emma Jones
Medicines Discovery Catapult
Dr Younbok Lee
King’s College London
Dr Younbok Lee
King’s College London
Dr Emma Mead
University of Oxford
Dr Emma Mead
University of Oxford
Prof Gareth Miles
University of St Andrews
Prof Gareth Miles
University of St Andrews
Dr Neil Miller
NRG Therapeutics
Dr Neil Miller
NRG Therapeutics
Dr Giovanni Nardo
Mario Negri Institute IRCCS
Dr Giovanni Nardo
Mario Negri Institute IRCCS
Prof Mónica Povedano
Bellvitge University Hospital
Prof Mónica Povedano
Bellvitge University Hospital
Dr Alastair Reith
Breckenfield Consulting Ltd
Dr Alastair Reith
Breckenfield Consulting Ltd
Dr Scott Sadler
Isomorphic Labs
Dr Scott Sadler
Isomorphic Labs
Dr Andrew Tosolini
The University of Queensland
Dr Andrew Tosolini
The University of Queensland
Bruce Virgo
Affected by MND
Bruce Virgo
Affected by MND
Dr Gillian Watt
Pharmaron UK
Dr Gillian Watt
Pharmaron UK
Our Discovery Network Advisory Board
Our Discovery Network Advisory Board oversees the due diligence of our Discovery Network funding. In addition to vetting applications, this group of academics, clinicians, industry representatives, and people affected by MND provides strategic guidance and advice on the delivery of our Discovery Network programme.
Prof Ludo Van Den Bosch
KU Leuven, Chair
Prof Ludo Van Den Bosch
KU Leuven, Chair
Dr Suchira Bose
Eli Lilly, Vice-Chair
Dr Suchira Bose
Eli Lilly, Vice-Chair
Prof Roger Barker
University of Cambridge
Prof Roger Barker
University of Cambridge
Prof Jenna Gregory
University of Aberdeen
Prof Jenna Gregory
University of Aberdeen
Dr Luke Hames-Brown
Affected by MND
Dr Luke Hames-Brown
Affected by MND
Prof John Hardy
University College London
Prof John Hardy
University College London
Prof Eva Hedlund
Stockholm University
Prof Eva Hedlund
Stockholm University
Prof Henry Houlden
University College London
Prof Henry Houlden
University College London
Prof Janine Kirby
University of Sheffield
Prof Janine Kirby
University of Sheffield
Dr Sarah Mizielinska
King's College London
Dr Sarah Mizielinska
King's College London
Dr Jennie Starkey
Affected by MND
Dr Jennie Starkey
Affected by MND
Davy Żyw
Affected by MND
Davy Żyw
Affected by MND
Our Scientific Advisors
Our Scientific Advisors assess and report to the Foundation on developments in MND research. The input we receive informs how we implement our research strategy, ensuring that we are adopting best practice approaches and keeping up to date with the latest developments. The strong relationships we cultivate make us a trusted voice in the MND community.
Our Scientific Advisors are not involved in the peer review of our funding applications and do not provide recommendations on which research projects we should fund. Find out more about how we invest in research here.
Ammar Al-Chalabi
King’s College London
Orla Hardiman
Trinity College Dublin
Andrea Malaspina
University College London
Christopher McDermott
University of Sheffield
Suvankar Pal
University of Edinburgh
Pamela Shaw
University of Sheffield
Kevin Talbot
University of Oxford
Martin Turner
University of Oxford
Carolyn Young
University of Liverpool
Hear about future funding
By subscribing, you confirm that you agree with our terms and conditions.